Authentidate Holding Corp. Reports Fiscal 2014 Fourth Quarter and Full Year …MarketWatchFollowing the end of the quarter, the company announced the completion of a registered direct offering of the company’s common stock and warrants for net proceeds of approximately $2.13 million. Ben Benjamin, Chief Executive Officer of Authentidate … and more …read more
Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and …PharmiWeb.com (press release)Asterias Biotherapeutics Inc. (OTCBB: ASTY) announced today that on October 1 2014 the company will distribute 8000000 warrants to purchase common shares of BioTime Inc. (the “BioTime Warrants”) at a purchase price of $5.00 per common share to … and more …read more
Lpath closes $12.5 million registered direct offeringNews-Medical.netAs previously disclosed, Lpath sold 3,605,042 registered shares of common stock and warrants to purchase 3,605,042 unregistered shares of common stock in a registered direct offering at a purchase price of $3.475 per share-and-warrant-share combination … and more …read more
Lpath closes $12.5 million registered direct offering – News-Medical.net Read More »
Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and …MarketWatchAsterias Series A common stock will trade on an ex-dividend basis without the BioTime Warrants commencing October 2, 2014 on the OTC Bulletin Board. The BioTime Warrants have been approved for listing on the NYSE MKT under the symbol BTX WS. and more …read more
Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and …DigitalJournal.comAsterias Series A common stock will trade on an ex-dividend basis without the BioTime Warrants commencing October 2, 2014 on the OTC Bulletin Board. The BioTime Warrants have been approved for listing on the NYSE MKT under the symbol BTX WS. …read more
Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and …Business Wire (press release)Asterias Series A common stock will trade on an ex-dividend basis without the BioTime Warrants commencing October 2, 2014 on the OTC Bulletin Board. The BioTime Warrants have been approved for listing on the NYSE MKT under the symbol BTX WS. and more
Lpath, Inc. Announces Closing of $12.5 Million Registered Direct OfferingDigitalJournal.comAs previously disclosed, Lpath sold 3,605,042 registered shares of common stock and warrants to purchase 3,605,042 unregistered shares of common stock in a registered direct offering at a purchase price of $3.475 per share-and-warrant-share combination … and more …read more
Lpath, Inc. Announces Closing of $12.5 Million Registered Direct OfferingCNNMoneyAs previously disclosed, Lpath sold 3,605,042 registered shares of common stock and warrants to purchase 3,605,042 unregistered shares of common stock in a registered direct offering at a purchase price of $3.475 per share-and-warrant-share combination … and more …read more
Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering – CNNMoney Read More »
Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSXSYS-CON Media (press release)… effective at market opening on September 30, 2014, Titan’s common shares and warrants will commence trading on the Toronto Stock Exchange (“TSX”). Concurrent with the TSX listing, the Company’s common shares and warrants will be de-listed from the … and
NeoStem Secures Debt FacilityCNNMoneyNo warrants or common stock were issued in connection with this financing. “This new debt facility will serve as an excellent source of non-dilutive capital to support the launch of our Intus Phase 3 clinical trial in metastatic melanoma, a significant … and more …read more
NeoStem Secures Debt Facility – CNNMoney Read More »